Sort
130,381 grants matching “hiv”
Transplant Models
$1,211,872Ronald Gress · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Vaccine and adjuvant Clinical GMP product development and DNA Technology platform enhancements
$1,211,603Trevor Smith · Wistar Institute · U19 · FY2024 · AI
HIV Persistence During Suppressive Antiretroviral Therapy
$1,211,385Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
A Multilevel HIV-Prevention Strategy for High-Risk Youth
$1,211,251Ralph J Diclemente · Emory University · U01 · FY2006 · MH
NATURAL HISTORY OF HIV INFECTION IN INJECTION DRUG USERS
$1,211,172Johns Hopkins University · R37 · FY2001 · DA
CAMELLIA Cohort: A longitudinal study to understand sexual health and prevention among women in Alabama
$1,211,161Latesha Ellen Elopre · University Of Alabama At Birmingham · R01 · FY2023 · HD
Non-Human Primate Core
$1,211,044Norman L Letvin · Duke University · U19 · FY2007 · AI
MEDICATION DEVELOPMENT UNIT FOR STIMULANT DEPENDENCE
$1,210,937Friends Research Institute, Inc. · P50 · FY2003 · DA
REPRIEVE COVID-19 Administrative Supplement
$1,210,912Steven Kyle Grinspoon · Massachusetts General Hospital · U01 · FY2020 · HL
REPRIEVE - CCC - Lead Application
$1,210,912Steven Kyle Grinspoon · Massachusetts General Hospital · U01 · FY2021 · HL
Development of Inhaled CPZEN-45 For Tuberculosis Therapy
$1,210,721Diana M Severynse-Stevens · Research Triangle Institute · R01 · FY2022 · AI
HIV vaccine swarms for PWID
$1,210,300Pablo Penaloza · Beth Israel Deaconess Medical Center · DP1 · FY2025 · DA
Factors Influencing Genetic Transcription Initiation And Termination
$1,210,070Robert J Crouch · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2013 · HD
Epidemiology, Prevention, and Treatment of Influenza and Other Respiratory Infect
$1,210,000Dean Barry Everett · University Of Liverpool · U01 · FY2016 · IP
PrEP and MOUD Rapid Access for Persons who Inject Drugs: the CHORUS+ Study
$1,209,970Sabrina A Assoumou · Boston Medical Center · R01 · FY2024 · DA
Centers for Innovative Research to Control AIDS
$1,209,927Wafaa M. El-Sadr · Columbia University Health Sciences · U01 · FY2007 · AI
Vanderbilt HIV Clinical Trials Unit
$1,209,774David W Haas · Vanderbilt University · UM1 · FY2013 · AI
Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU)
$1,209,654Suwat Chariyalertsak · Chiang Mai University · UM1 · FY2016 · AI
IMMUNOPATHOGENESIS OF ACUTE HIV-1 INFECTION
$1,209,516University Of Colorado Denver · U01 · FY2000 · AI
The Impact of Early Medical Treatment in Transgender Youth
$1,209,157Johanna L Olson-Kennedy · Children'S Hospital Of Los Angeles · R01 · FY2018 · HD
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users
$1,209,100Lisa R Metsch · Columbia University Health Sciences · R01 · FY2013 · DA
Units for HIV/AIDS Clinical Trials Networks
$1,208,979Ram Yogev · Lurie Children'S Hospital Of Chicago · UM1 · FY2013 · AI
Project 3
$1,208,757Alexander Marson · University Of California, San Francisco · U54 · FY2025 · AI
Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Markets and Drug Tourism
$1,208,754Steffanie A Strathdee · University Of California, San Diego · R01 · FY2021 · DA
Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care
$1,208,520Bruce R Schackman · Weill Medical Coll Of Cornell Univ · P30 · FY2015 · DA